20th World Conference on Pharmaceutical Chemistry and Drug Design

Starts On: 03/09/2018
Ends At: 05/09/2018
Country: United Arab Emirates
City: Dubai
Faculty: Pharmacy
Contact Email: pharmaceuticalchemistry@pharmameetings.com
Contact Phone: 7025085200
Download Abstracts
Conference Website
1 Star2 Stars3 Stars4 Stars5 Stars (2 votes, average: 5.00 out of 5)



About Conference

ME Conferences invites all the participants across the globe to attend a 20th world conference on pharmaceutical chemistry and Drug Design during September 03-05, 2018 at Dubai which includes innovative keynote presentations, lectures, Poster presentations and workshops or symposiums. Pharm Chem 2018 Congress is a specially designed gathering Pharmaceutical and Medicinal Chemistry Conference. The main theme of this Pharma conferences is “Exceeding the vision in drug and pharmaceutical chemistry” which covers a wide range of critically important sessions.

Why attend?

Enable participants to exchange ideas and expand the network with leading pharmaceutical scientists and professionals. Drug pharma chemistry 2018 brings together top international scientists and professionals presenting cutting-edge discoveries, research, and new therapeutic drugs. Enable exhibitors to have increased visibility through branding and networking at the conference and gain direct access to a core audience of professionals and decision makers.

Important Dates:

Abstract Submission Opens November 14, 2017
Registration Opens November 21, 2017
Early Bird Registration January 22, 2018
On Spot Registration September 03, 2018


Track 1: Drug Designing

Drug design is an inventive process of medication discovered by a biological target. It is also known as rational drug design or rational design. The drug is most commonly an organic small molecule that activates or inhibits the function of a biomolecule such as a protein, which in turn results in a therapeutic benefit to the patient. In the most basic sense. Drug design relies on the knowledge of the three-dimensional structure of biomolecular targets. The drug is an organic molecule when it is a predicament to target site it can either inhibit or activate the function of a biomolecule which effects in therapeutic benefit.

  • Track 1-1Research & development in drug designing
  • Track 1-2Drug targets
  • Track 1-3Drug designing docking
  • Track 1-4Types of drug design
  • Track 1-5Structural based drug designing
  • Track 1-6Pharmacoepidemiology

Track 2: Pharmaceutical Organic Chemistry

Organic chemistry is a chemistry subdiscipline involving the scientific study of the structure, properties, and reactions of organic compounds and organic materials, i.e., matter in its various forms that contain carbon atoms. It includes many physical and chemical method to determine the compound and materials. Study of molecules includes both physical properties and chemical properties and uses similar methods, so as to evaluate chemical reactivity. The variety of compounds studied in organic chemistry include hydrocarbons, as well as myriad compositions based always on carbon. In addition, organic chemistry involves further organometallics the lanthanides, but especially transition metals (zinc, copper, nickel, cobalt, titanium and chromium).

  • Track 2-1Organometallic chemistry
  • Track 2-2Techniques in organic chemistry
  • Track 2-3 Chemical reactions in pharma organic chemistry
  • Track 2-4Future aspects of organic chemistry

Track 3: Drug Target Discovery

The term drug targets regularly used in medicinal research to describe the native protein in the body whose activity is modified by a drug resulting in a distinct effect, which may be a desirable therapeutic effect or an unwanted side effect. In this context, the biological target is often referred to as a biological target. The most common drug targets are G-protein coupled receptor, enzymes, ligand-gated channels, voltage-gated channels, ion channels, nuclear hormone receptor and membrane transport proteins

  • Track 3-1Drug targeting
  • Track 3-2Drug toxicity
  • Track 3-3Drug designing
  • Track 3-4Drug design strategies for targeting g-protein-coupled receptors
  • Track 3-5Biological targets
  • Track 3-6Rational drug design

Track 4: Pharmaceutical Drug Discovery and Nanotechnology

Nanotechnology has now introduced to develop medicine. Nanotechnology contains the use of materials with essential length scales in the nanometer measurement which demonstrates significantly changed properties associated with micron structured materials. Such materials can include particles, fibers, grain sizes, etc. This session highlighted the progressions nanotechnology is making in medicine in such fields as disease prevention, diagnosis, and treatment including (but not limited to) drug delivery, tissue engineering, implants, sensors, cancer treatment, a but not limited to) drug delivery, tissue engineering, transplants, sensors, cancer treatment, and toxic

  • Track 4-1Current research in nanotechnology
  • Track 4-2Nanotechnology methods in drug design
  • Track 4-3optimization techniques in drug discovery
  • Track 4-4Future aspects of drug discovery and nanotechnology
0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *